EAGLE ASSET MANAGEMENT INC – Halozyme Therapeutics, Inc. Transaction History
EAGLE ASSET MANAGEMENT INC portfolio value:
$52.39M
portfolio value
EAGLE ASSET MANAGEMENT INC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -5.00% | -69.71K shares | -8.97M | $39.54 | 1.32M |
| Q2 2022 | share | Increase | +16.41% | 196.63K shares | 13.58M | $44 | 1.39M |
| Q1 2022 | share | Decrease | -4.65% | -58.43K shares | -2.88M | $39.88 | 1.19M |
| Q4 2021 | share | Decrease | -14.35% | -210.54K shares | -9.01M | $40.32 | 1.25M |
| Q3 2021 | share | Decrease | -13.58% | -230.45K shares | -17.40M | $40.68 | 1.46M |
| Q2 2021 | share | Decrease | -4.20% | -74.45K shares | 1.9M | $45.41 | 1.69M |
| Q1 2021 | share | Decrease | -4.77% | -88.70K shares | -4.28M | $41.69 | 1.77M |
| Q4 2020 | share | Decrease | -13.00% | -278.01K shares | 22.77M | $42.71 | 1.86M |
| Q3 2020 | share | Increase | +1.32% | 27.85K shares | 2.19M | $26.28 | 2.13M |
| Q2 2020 | share | Decrease | -0.14% | -2.91K shares | 16.47M | $26.81 | 2.11M |
| Q1 2020 | share | Increase | +37.96% | 581.64K shares | 10.86M | $17.99 | 2.11M |
| Q4 2019 | share | Decrease | -0.55% | -8.47K shares | 3.27M | $17.73 | 1.53M |
| Q3 2019 | share | Increase | 0.00% | 1.54M shares | 23.89M | $15.51 | 1.54M |